Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant HPV vaccination and HPV screening in Swedish women aged 23-25
2020-001169-34Phase 4Active
- Sponsor
- Region Stockholm
- Start
- Feb 2021
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection and Cervical Cancer (CC) (2 arms), sponsored by Region Stockholm. Started Feb 2021; status: active.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infectionCervical Cancer (CC)
Beyond the preview
Go deeper on 2020-001169-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001169-34.